These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 26747707)

  • 1. Transcriptional Regulation of miR-31 by Oncogenic KRAS Mediates Metastatic Phenotypes by Repressing RASA1.
    Kent OA; Mendell JT; Rottapel R
    Mol Cancer Res; 2016 Mar; 14(3):267-77. PubMed ID: 26747707
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An oncogenic KRAS transcription program activates the RHOGEF ARHGEF2 to mediate transformed phenotypes in pancreatic cancer.
    Kent OA; Sandí MJ; Burston HE; Brown KR; Rottapel R
    Oncotarget; 2017 Jan; 8(3):4484-4500. PubMed ID: 27835861
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MicroRNA-31 activates the RAS pathway and functions as an oncogenic MicroRNA in human colorectal cancer by repressing RAS p21 GTPase activating protein 1 (RASA1).
    Sun D; Yu F; Ma Y; Zhao R; Chen X; Zhu J; Zhang CY; Chen J; Zhang J
    J Biol Chem; 2013 Mar; 288(13):9508-18. PubMed ID: 23322774
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MiR-21/RASA1 axis affects malignancy of colon cancer cells via RAS pathways.
    Gong B; Liu WW; Nie WJ; Li DF; Xie ZJ; Liu C; Liu YH; Mei P; Li ZJ
    World J Gastroenterol; 2015 Feb; 21(5):1488-97. PubMed ID: 25663768
    [TBL] [Abstract][Full Text] [Related]  

  • 5. KRAS Mutation-Responsive miR-139-5p inhibits Colorectal Cancer Progression and is repressed by Wnt Signaling.
    Du F; Cao T; Xie H; Li T; Sun L; Liu H; Guo H; Wang X; Liu Q; Kim T; Franklin JL; Graves-Deal R; Han W; Tian Z; Ge M; Nie Y; Fan D; Coffey RJ; Lu Y; Zhao X
    Theranostics; 2020; 10(16):7335-7350. PubMed ID: 32641995
    [No Abstract]   [Full Text] [Related]  

  • 6. miR-802 Suppresses Acinar-to-Ductal Reprogramming During Early Pancreatitis and Pancreatic Carcinogenesis.
    Ge W; Goga A; He Y; Silva PN; Hirt CK; Herrmanns K; Guccini I; Godbersen S; Schwank G; Stoffel M
    Gastroenterology; 2022 Jan; 162(1):269-284. PubMed ID: 34547282
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MiR-143-3p suppresses tumorigenesis in pancreatic ductal adenocarcinoma by targeting KRAS.
    Xie F; Li C; Zhang X; Peng W; Wen T
    Biomed Pharmacother; 2019 Nov; 119():109424. PubMed ID: 31521891
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNAs 206 and 21 cooperate to promote RAS-extracellular signal-regulated kinase signaling by suppressing the translation of RASA1 and SPRED1.
    Sharma SB; Lin CC; Farrugia MK; McLaughlin SL; Ellis EJ; Brundage KM; Salkeni MA; Ruppert JM
    Mol Cell Biol; 2014 Nov; 34(22):4143-64. PubMed ID: 25202123
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNA-223 Regulates Cardiac Fibrosis After Myocardial Infarction by Targeting RASA1.
    Liu X; Xu Y; Deng Y; Li H
    Cell Physiol Biochem; 2018; 46(4):1439-1454. PubMed ID: 29689569
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long noncoding RNA SNHG14 accelerates cell proliferation, migration, invasion and suppresses apoptosis in colorectal cancer cells by targeting miR-944/KRAS axis through PI3K/AKT pathway.
    Pei Q; Liu GS; Li HP; Zhang Y; Xu XC; Gao H; Zhang W; Li T
    Eur Rev Med Pharmacol Sci; 2019 Nov; 23(22):9871-9881. PubMed ID: 31799655
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypoxia-induced lncRNA-NUTF2P3-001 contributes to tumorigenesis of pancreatic cancer by derepressing the miR-3923/KRAS pathway.
    Li X; Deng SJ; Zhu S; Jin Y; Cui SP; Chen JY; Xiang C; Li QY; He C; Zhao SF; Chen HY; Niu Y; Liu Y; Deng SC; Wang CY; Zhao G
    Oncotarget; 2016 Feb; 7(5):6000-14. PubMed ID: 26755660
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Establishment of a non‑coding RNAomics screening platform for the regulation of KRAS in pancreatic cancer by RNA sequencing.
    Zhang L; Yu S; Wang C; Jia C; Lu Z; Chen J
    Int J Oncol; 2018 Dec; 53(6):2659-2670. PubMed ID: 30221677
    [TBL] [Abstract][Full Text] [Related]  

  • 13. p120RasGAP is a mediator of rho pathway activation and tumorigenicity in the DLD1 colorectal cancer cell line.
    Organ SL; Hai J; Radulovich N; Marshall CB; Leung L; Sasazuki T; Shirasawa S; Zhu CQ; Navab R; Ikura M; Tsao MS
    PLoS One; 2014; 9(1):e86103. PubMed ID: 24465899
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MAP kinase and autophagy pathways cooperate to maintain RAS mutant cancer cell survival.
    Lee CS; Lee LC; Yuan TL; Chakka S; Fellmann C; Lowe SW; Caplen NJ; McCormick F; Luo J
    Proc Natl Acad Sci U S A; 2019 Mar; 116(10):4508-4517. PubMed ID: 30709910
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Construction of has-miR-335 lentiviral vector and verification of the target gene of miR-335].
    Yang H; Zhang C; Lu YX; Wu XJ; Yuan L; Zhou C; Zhou CP; Liu GB; Li XN
    Nan Fang Yi Ke Da Xue Xue Bao; 2012 Mar; 32(3):306-11. PubMed ID: 22445972
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The lncRNA MALAT1 acts as a competing endogenous RNA to regulate KRAS expression by sponging miR-217 in pancreatic ductal adenocarcinoma.
    Liu P; Yang H; Zhang J; Peng X; Lu Z; Tong W; Chen J
    Sci Rep; 2017 Jul; 7(1):5186. PubMed ID: 28701723
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 4-Acetyl-Antroquinonol B Improves the Sensitization of Cetuximab on Both Kras Mutant and Wild Type Colorectal Cancer by Modulating the Expression of Ras/Raf/miR-193a-3p Signaling Axis.
    Chu YC; Tsai TY; Yadav VK; Deng L; Huang CC; Tzeng YM; Yeh CT; Chen MY
    Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34299137
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNA-425-5p Expression Affects BRAF/RAS/MAPK Pathways In Colorectal Cancers.
    Angius A; Pira G; Scanu AM; Uva P; Sotgiu G; Saderi L; Manca A; Serra C; Uleri E; Piu C; Caocci M; Ibba G; Zinellu A; Cesaraccio MR; Sanges F; Muroni MR; Dolei A; Cossu-Rocca P; De Miglio MR
    Int J Med Sci; 2019; 16(11):1480-1491. PubMed ID: 31673240
    [TBL] [Abstract][Full Text] [Related]  

  • 19. RREB1 repressed miR-143/145 modulates KRAS signaling through downregulation of multiple targets.
    Kent OA; Fox-Talbot K; Halushka MK
    Oncogene; 2013 May; 32(20):2576-85. PubMed ID: 22751122
    [TBL] [Abstract][Full Text] [Related]  

  • 20. C/EBP-β-activated microRNA-223 promotes tumour growth through targeting RASA1 in human colorectal cancer.
    Sun D; Wang C; Long S; Ma Y; Guo Y; Huang Z; Chen X; Zhang C; Chen J; Zhang J
    Br J Cancer; 2015 Apr; 112(9):1491-500. PubMed ID: 25867276
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.